Table 1.
Overview of clinical data before and after irradiation and irradiation parameters
| Variable | Overall | Average | |
|---|---|---|---|
| N | 73 | ||
| Age (range) | (30–82) | 60 (mean) | |
| No. of surgeries (range) | (0–4) | 1.41 (mean) | |
| Fractionation | |||
| SRS | 5 | 7 % | |
| SRT | 67 | 92 % | |
| (hf) SRT | 1 | 1 % | |
| RT | Adjuvant | 63 | 86 % |
| primary | 10 | 14 % | |
| CTV (range), ccm | (0.58–57.29) | 7.02 (mean) | |
| SRS | (1.04–1.94) | 1.69 (median) | |
| SRT | (0.58–57.29) | 4.05 (median) | |
| (hf) SRT | 2.21 | ||
| Fx (range) | (1.00–31.00) | ||
| SRS | 1 | ||
| SRT | 25–31 | 26 (mean) | |
| (hf) SRT | 7 | ||
| Daily dose, Gy | |||
| SRS | 15, 18, 20 | ||
| SRT | 1.8–2.0 | ||
| (hf) SRT | 5 | ||
| Total dose (range), Gy | (15.00–56.00) | ||
| SRS | 18, 20, 30 | ||
| SRT | 45–62 | 52 (median) | |
| (hf) SRT | 35 | ||
| Follow up (range) years | (0.5–11.0) | 5.16 (mean) | |
| Tumor size (at last follow-up) | |||
| Smaller | 48 | 66 % | |
| Stable | 25 | 34 % | |
| Larger | 0 | 0 % | |
| N.D. | 0 | ||
| Hypopituitarism (before RT) | |||
| Full | 32 | 43.8 % | |
| Partial | 12 | 16.4 % | |
| None | 29 | 39.7 % | |
| N.D. | 0 | ||
| Hypopituitarism (after RT) | |||
| Full | 39 | 53.4 % | |
| Partial | 15 | 20.5 % | |
| None | 19 | 26.0 % | |
| N.D. | 0 | ||
| Dysfunction of optical system (before RT) | |||
| Yes | 36 | 49.3 % | |
| None | 37 | 50.7 % | |
| Dysfunction of optical system (after RT) | |||
| None | 36 | 49.3 % | |
| Idem | 31 | 42.5 % | |
| Improvement | 3 | 4.1 % | |
| Aggravation | 3 | 4.1 % |
RT radiotherapy, SRS stereotactic radiosurgery, SRT stereotactic radiotherapy, (hf) SRT hypofractionated stereotactic radiotherapy, CTV clinical target volume, Gy Gray, N.D. not done